{"title":"BJP volume 222 issue 3 Cover and Back matter","authors":"","doi":"10.1192/bjp.2023.18","DOIUrl":"https://doi.org/10.1192/bjp.2023.18","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87883380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Depersonalization and Creative Writing By Matthew Francis. Routledge. 2022. £120 (hb). 188 pp. ISBN: 9780367530686","authors":"Stephen Wilson","doi":"10.1192/bjp.2022.142","DOIUrl":"https://doi.org/10.1192/bjp.2022.142","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90324343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Koro: Clinical and Historical Developments of the Culturally Defined Genital Retraction Disorder By Arabinda Narayan Chowdhury. Palgrave Macmillan. 2021. £99.99 (hb). 518 pp. ISBN: 9783030879617","authors":"F. Oyebode","doi":"10.1192/bjp.2022.156","DOIUrl":"https://doi.org/10.1192/bjp.2022.156","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72733942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BJP volume 222 issue 3 Cover and Front matter","authors":"","doi":"10.1192/bjp.2023.17","DOIUrl":"https://doi.org/10.1192/bjp.2023.17","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79718930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Matter with Things: Our Brains, Our Delusions, and the Unmaking of the World By Iain McGilchrist. Perspectiva. 2021. £89.95 (hb). 1500 pp. ISBN: 9781914568060","authors":"Annie Swanepoel","doi":"10.1192/bjp.2022.147","DOIUrl":"https://doi.org/10.1192/bjp.2022.147","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91517997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jenna has multiple sclerosis, and her life journey is one of the stories that are worth narrating. During one of her visits to her consultant’s office, she paused and looked wistfully out the ground-floor office window. ‘It was now late September, and on this cloudless, chilly day, the maple was in full fall foliage. “How lovely”, she murmured to herself, her gaze arrested by the blaze of color. She fell silent, a shaft of late afternoon sunlight falling across her finely chiseled features, the subtle interplay of light and shadow accentuating her melancholy with Caravaggio-like effect’. Finding references to Caravaggio’s style and even poetic alliterations (‘full fall foliage’) does not often happen within medical writings. However, this is arguably a representative sample from Anthony Feinstein’s new book on the neuropsychiatry of multiple sclerosis. Feinstein is equally talented as a clinician and as a writer. As a clinical scientist, he is a world-renown neuropsychiatrist who needs no introduction. His clinical activity at the multiple sclerosis clinic spans three decades: during that time he has assessed and treated thousands of people. He has painstakingly collected their unique life stories, which share the challenge presented by living with multiple sclerosis. By his own admission, he has created the fictional people who populate his new book ‘by reworking, modifying, altering, combining, trimming, expanding, and reinventing the gist of these real-life stories’. Feinstein’s eloquent case histories focus on the psychiatric disorders that often accompany the neurological manifestations of multiple sclerosis: from the peculiar affective symptoms (pseudobulbar affect) to the kaleidoscopic changes in personality and behaviour. The most commonly reported cognitive difficulties – slowed information processing speed, impaired memory, and deficits in executive function – are presented in real-life scenarios, illustrating the impact on people’s everyday activities. Endorsed by the Consortium of Multiple Sclerosis Centers, this book also provides tailored recommendations for evidence-based therapeutic interventions. The comprehensive and up-to-date reference list at the end of the volume reflects its alignment with the latest science. Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis ideally complements Feinstein’s previous volume, titled The Clinical Neuropsychiatry of Multiple Sclerosis (1999). Any health professional involved in the care of people with multiple sclerosis would benefit from reading these books, regardless of their specialty. Thanks to Feinstein’s engaging and accessible style, his latest effort is equally appealing to people with multiple sclerosis and their families. Andrea E. Cavanna , Michael Trimble Neuropsychiatry Research Group, Birmingham and Solihull Mental Health NHS Foundation Trust and University of Birmingham, UK; School of Life and Health Sciences, Aston University, UK; and Sobell Departme
珍娜患有多发性硬化症，她的人生旅程是值得讲述的故事之一。有一次去咨询师的办公室，她停下来，若有所思地从一楼办公室的窗户往外看。现在是九月下旬，在这个万里无云、寒冷的日子里，枫叶开满了秋叶。“多可爱啊!”她喃喃自语，她的目光被绚丽的色彩吸引住了。她陷入了沉默，一缕傍晚的阳光洒在她轮廓分明的脸上，光影的微妙相互作用以卡拉瓦乔式的效果加重了她的忧郁。在医学著作中，发现卡拉瓦乔的风格甚至诗歌的头韵(“满地落叶”)并不常见。然而，这可以说是安东尼·范斯坦(Anthony Feinstein)关于多发性硬化症神经精神病学的新书中的一个代表性样本。范斯坦是一位才华横溢的临床医生，也是一位作家。作为一名临床科学家，他是世界知名的神经精神病学家，无需介绍。他在多发性硬化症诊所的临床活动长达三十年:在此期间，他评估和治疗了数千人。他煞费苦心地收集了他们独特的生活故事，这些故事分享了患有多发性硬化症所带来的挑战。据他自己承认，他“通过对这些真实故事的要点进行再加工、修改、改变、组合、修剪、扩展和重新创造”，创造出了在他的新书中出现的虚构人物。范斯坦雄辩的病历集中在经常伴随多发性硬化症的神经系统表现的精神疾病上:从特殊的情感症状(假性球影响)到性格和行为的千变万化的变化。最常见的认知困难——信息处理速度减慢、记忆受损和执行功能缺陷——在现实生活中出现，说明了对人们日常活动的影响。由多发性硬化症中心联盟的认可，这本书还提供了量身定制的建议，以证据为基础的治疗干预。在卷的末尾，全面和最新的参考书目反映了它与最新科学的一致性。《精神、情绪和记忆:多发性硬化症的神经行为后果》一书完美地补充了范斯坦之前的著作《多发性硬化症的临床神经精神病学》(1999)。任何参与治疗多发性硬化症患者的健康专业人士，无论他们的专业是什么，都能从这些书中受益。由于范斯坦引人入胜、平易近人的风格，他的最新作品同样吸引了多发性硬化症患者及其家人。Andrea E. Cavanna, Michael Trimble神经精神病学研究小组，伯明翰和索利赫尔精神健康NHS基金会信托基金和伯明翰大学，英国;英国阿斯顿大学生命与健康科学学院;伦敦大学学院运动神经科学和运动障碍索贝尔系和英国神经病学研究所。电子邮件:a.cavanna@nhs.net
{"title":": The Neurobehavioral Consequences of Multiple Sclerosis","authors":"W. Busuttil","doi":"10.1192/bjp.2022.125","DOIUrl":"https://doi.org/10.1192/bjp.2022.125","url":null,"abstract":"Jenna has multiple sclerosis, and her life journey is one of the stories that are worth narrating. During one of her visits to her consultant’s office, she paused and looked wistfully out the ground-floor office window. ‘It was now late September, and on this cloudless, chilly day, the maple was in full fall foliage. “How lovely”, she murmured to herself, her gaze arrested by the blaze of color. She fell silent, a shaft of late afternoon sunlight falling across her finely chiseled features, the subtle interplay of light and shadow accentuating her melancholy with Caravaggio-like effect’. Finding references to Caravaggio’s style and even poetic alliterations (‘full fall foliage’) does not often happen within medical writings. However, this is arguably a representative sample from Anthony Feinstein’s new book on the neuropsychiatry of multiple sclerosis. Feinstein is equally talented as a clinician and as a writer. As a clinical scientist, he is a world-renown neuropsychiatrist who needs no introduction. His clinical activity at the multiple sclerosis clinic spans three decades: during that time he has assessed and treated thousands of people. He has painstakingly collected their unique life stories, which share the challenge presented by living with multiple sclerosis. By his own admission, he has created the fictional people who populate his new book ‘by reworking, modifying, altering, combining, trimming, expanding, and reinventing the gist of these real-life stories’. Feinstein’s eloquent case histories focus on the psychiatric disorders that often accompany the neurological manifestations of multiple sclerosis: from the peculiar affective symptoms (pseudobulbar affect) to the kaleidoscopic changes in personality and behaviour. The most commonly reported cognitive difficulties – slowed information processing speed, impaired memory, and deficits in executive function – are presented in real-life scenarios, illustrating the impact on people’s everyday activities. Endorsed by the Consortium of Multiple Sclerosis Centers, this book also provides tailored recommendations for evidence-based therapeutic interventions. The comprehensive and up-to-date reference list at the end of the volume reflects its alignment with the latest science. Mind, Mood, and Memory: The Neurobehavioral Consequences of Multiple Sclerosis ideally complements Feinstein’s previous volume, titled The Clinical Neuropsychiatry of Multiple Sclerosis (1999). Any health professional involved in the care of people with multiple sclerosis would benefit from reading these books, regardless of their specialty. Thanks to Feinstein’s engaging and accessible style, his latest effort is equally appealing to people with multiple sclerosis and their families. Andrea E. Cavanna , Michael Trimble Neuropsychiatry Research Group, Birmingham and Solihull Mental Health NHS Foundation Trust and University of Birmingham, UK; School of Life and Health Sciences, Aston University, UK; and Sobell Departme","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79545616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BJP volume 222 issue 2 Cover and Back matter","authors":"","doi":"10.1192/bjp.2022.208","DOIUrl":"https://doi.org/10.1192/bjp.2022.208","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75246113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Seminars in the Psychotherapies (2nd edn) Edited by Rachel Gibbons and Jo O'Reilly. Cambridge University Press. 2021. £39.99 (pb). 414 pp. ISBN: 9781108711838","authors":"A. Baban","doi":"10.1192/bjp.2022.136","DOIUrl":"https://doi.org/10.1192/bjp.2022.136","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86949637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BJP volume 222 issue 2 Cover and Front matter","authors":"","doi":"10.1192/bjp.2022.207","DOIUrl":"https://doi.org/10.1192/bjp.2022.207","url":null,"abstract":"","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88228706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this issue of BJPsych, the editorial by Goodday et al (pp. 51–53) argues that digital health technologies could potentially redesign the psychiatry field. We base our assessment and treatment on self-reported symptoms in intermittent clinical encounters. What if we could bring more objectivity to our practice? Like Holter monitoring for blood pressure, can we monitor dynamic behaviour, emotion and physiological responses in real time? In the related Analysis, Rocheteau elegantly outlines the issues associated with artificial intelligence in psychiatry. Of note, Rocheteau touches on the idea of online psychotherapy. What if we replace human therapists with ‘robo-therapists’who can recall your story, deep learn and stick to manualised therapy perfectly? We already have the technology to produce speech that is indistinguishable from that of humans. The future may be closer than we think it is. The multicentre randomised control trial by Gnanapragasam et al (pp. 58–66) brings us back to reality. The study examines the effectiveness of the ‘Foundations’ app among UK healthcare workers. The app reduced general psychiatric morbidity and insomnia while improving the mental well-being of the intervention group. The app did not, however, have any significant impact on symptoms of depression or anxiety, or on resilience, presenteeism and functioning. Another paper on COVID in this issue Fancourt et al (pp. 74–81) further examines depressive and anxiety symptoms. Using data from the UCL COVID-19 Social Study, the authors found that compared with the short-COVID group, those with long COVID experienced significantly higher levels of depressive symptoms but comparable levels of anxiety symptoms at the onset of COVID infection. Over the subsequent 22 months, both the depressive and anxiety symptoms for the long-COVID group remained elevated whereas the symptoms were reduced back to the baseline for the short-COVID group. Even in a developed nation like Australia where I practice, pharmacological intervention is vastly more available and affordable (and thus accessible) than psychological intervention. I can only imagine how limited access might be in lowand middle-income countries with a distinct lack of trained professionals. The Healthy Activity Program trial demonstrated that you don’t need fancy degrees to help people. Through the programme, behavioural activation delivered by lay counsellors in Goa, India, significantly improved the remission rate from depression. In this issue, Seward et al (pp. 67–73) further explore the data from the trial to see if they could find specific aspects that improved outcomes. The authors found that the reduction in depressive symptoms was mediated through improved levels of behavioural activation. Surprisingly, they found no mediating effects through factors such as the number of sessions, homework completed, response to therapy or number of additional sessions. Given the findings, the authors suggested that if people ar
{"title":"Highlights of this issue","authors":"S. Suetani","doi":"10.1192/bjp.2022.186","DOIUrl":"https://doi.org/10.1192/bjp.2022.186","url":null,"abstract":"In this issue of BJPsych, the editorial by Goodday et al (pp. 51–53) argues that digital health technologies could potentially redesign the psychiatry field. We base our assessment and treatment on self-reported symptoms in intermittent clinical encounters. What if we could bring more objectivity to our practice? Like Holter monitoring for blood pressure, can we monitor dynamic behaviour, emotion and physiological responses in real time? In the related Analysis, Rocheteau elegantly outlines the issues associated with artificial intelligence in psychiatry. Of note, Rocheteau touches on the idea of online psychotherapy. What if we replace human therapists with ‘robo-therapists’who can recall your story, deep learn and stick to manualised therapy perfectly? We already have the technology to produce speech that is indistinguishable from that of humans. The future may be closer than we think it is. The multicentre randomised control trial by Gnanapragasam et al (pp. 58–66) brings us back to reality. The study examines the effectiveness of the ‘Foundations’ app among UK healthcare workers. The app reduced general psychiatric morbidity and insomnia while improving the mental well-being of the intervention group. The app did not, however, have any significant impact on symptoms of depression or anxiety, or on resilience, presenteeism and functioning. Another paper on COVID in this issue Fancourt et al (pp. 74–81) further examines depressive and anxiety symptoms. Using data from the UCL COVID-19 Social Study, the authors found that compared with the short-COVID group, those with long COVID experienced significantly higher levels of depressive symptoms but comparable levels of anxiety symptoms at the onset of COVID infection. Over the subsequent 22 months, both the depressive and anxiety symptoms for the long-COVID group remained elevated whereas the symptoms were reduced back to the baseline for the short-COVID group. Even in a developed nation like Australia where I practice, pharmacological intervention is vastly more available and affordable (and thus accessible) than psychological intervention. I can only imagine how limited access might be in lowand middle-income countries with a distinct lack of trained professionals. The Healthy Activity Program trial demonstrated that you don’t need fancy degrees to help people. Through the programme, behavioural activation delivered by lay counsellors in Goa, India, significantly improved the remission rate from depression. In this issue, Seward et al (pp. 67–73) further explore the data from the trial to see if they could find specific aspects that improved outcomes. The authors found that the reduction in depressive symptoms was mediated through improved levels of behavioural activation. Surprisingly, they found no mediating effects through factors such as the number of sessions, homework completed, response to therapy or number of additional sessions. Given the findings, the authors suggested that if people ar","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85854397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：